AVA-291 is a novel testosterone formulation for women, designed to resist aromatization and reduce breast cancer risk. Data shows AVA-291 has a 1,000-fold lower potential to stimulate breast cancer ...
Pedro F.S. Freitas, MD, recaps his talk at the 2026 Desai Sethi Urology Institute Urology on the Beach meeting. In an interview at the 2026 Desai Sethi Urology Institute Urology on the Beach meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results